Figure 2From: Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer Recurrence - free survival rates according to neutrophil - lymphocyte ratio ( NLR ). The 5-year recurrence-free survival rate was 61.2% and 14.6% in patients with NLR < 3 and NLR ≥ 3, respectively (p = 0.01).Back to article page